| |
Blood
AU- Abdullah, J.M., and X. Jing and D.S. Spassov and R.G. Nachtman and R. Jurecic
TI- "Cloning and characterization of Hepp, a novel gene expressed preferentially in hematopoietic progenitors and mature blood cells."
SO- Blood Cells Molecules and Diseases 27, no. 3 (2001): 667-676.
UM- mic-Jurecic, Roland / AU- Abdullah, J.M., and X.Y. Li and R.G. Nachtman and R. Jurecic
TI- "FLRF, a novel evolutionarily conserved RING finger gene, is differentially expressed in mouse fetal and adult hematopoietic stem cells and progenitors."
SO- Blood Cells Molecules and Diseases 27, no. 1 (2001): 320-333.
UM- mic-Jurecic, Roland / AU- Flinn, I.W., and K.J. Kopecky and M.K. Foucar and D. Head and J.M. Bennett and R. Huchison and W. Corbett and P.A. Cassileth and T. Habermann and H. Golomb and K. Rai and E. Eisenhauer and F. Appelbaum and B. Cheson and M.R. Grever
TI- "Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin."
SO- Blood 96, no. 9 (2000): 2981-2986.
UM- mdd-Cassileth, Peter A. / AU- Gordon, L.I., and M. Young and E. Weller and T.M. Habermann and J.N. Winter and J. Glick and C. Ghosh and P. Flynn and P.A. Cassileth
TI- "A phase II trial of 200% ProMACE-CytaBOM-in patients with previously untreated aggressive lymphomas: Analysis of response, toxicity, and dose intensity."
SO- Blood 94, no. 10 (1999): 3307-3314.
UM- mdd-Cassileth, Peter A. / AU- Grad, J.M., and N.J. Bahlis and I.M. Reis and M.M. Oshiro and W.S. Dalton and L.H. Boise
TI- "Ascorbic acid enhances arsenic trioxide-induced cytotoxicity in multiple myeloma cells."
SO- Blood 98, no. 3 (2001): 805-813.
UM- epi-Reis, Isildinha M. / mic-Boise, Lawrence H. / AU- Jiang, Z., and E.R. Podack and R.B. Levy
TI- "Major histocompatibility complex-mismatched allogeneic bone marrow transplantation using perforin and/or Fas ligand double-defective CD4(+) donor T cells: involvement of cytotoxic function by donor lymphocytes prior to graft-versus-host disease pathogenes."
SO- Blood 98, no. 2 (2001): 390-397.
UM- mic-Podack, Eckhard R. / mic-Levy, Robert B. / AU- Mannucci, P.M., and J. Chediak and W. Hanna and J.J. Byrnes and M. Ledford and B.M. Ewenstein and A.D. Retzios and B.A. Kapelan and R.S. Schwartz and C. Kessler
TI- "Treatment of von Willebrand disease with a high-purity factor VIII/von Willebrand factor concentrate: a prospective, multicenter study."
SO- Blood 99, no. 2 (2002): 450-456.
UM- pth-Ledford, Marlies / mdd-Byrnes, John J. / AU- Muller-Sieburg, C.E., and R.H. Cho and M. Thoman and B. Adkins and H.B. Sieburg
TI- "Deterministic regulation of hematopoietic stem cell self-renewal and differentiation."
SO- Blood 100, no. 4 (2002): 1302-1309.
UM- mic-Adkins, Rebecca D. / AU- Munoz, S.J., and H.J. Alter and Y. Nakatsuji and J.W.K. Shih and R.K. Reddy and L.J. Jeffers and E.R. Schiff and A.E. Reid and A. Marrone and K. Rothstein and C. Manzarbeitia and T.J. Liang
TI- "The significance of hepatitis G virus in serum of patients with sporadic fulminant and subfulminant hepatitis of unknown etiology."
SO- Blood 94, no. 4 (1999): 1460-1464.
UM- mdd-Schiff, Eugene R. / mdd-Jeffers, Lennox J. / mdd-Reddy, K. Rajender / AU- Ohene-Frempong, K., and S.J. Weiner and L.A. Sleeper and S.T. Miller and S. Embury and J.W. Moohr and D.L. Wethers and C.H. Pegelow and F.M. Gill
TI- "Cerebrovascular accidents in sickle cell disease: Rates and risk factors."
SO- Blood 91, no. 1 (1998): 288-294.
UM- ped-Pegelow, Charles H. / AU- Pegelow, C.H., and E.A. Macklin and F.G. Moser and W.C. Wang and J.A. Bello and S.T. Miller and E.P. Vichinsky and M.R. Debaun and L. Guarini and R.A. Zimmerman and D.P. Younkin and D.M. Gallagher and T.R. Kinney
TI- "Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease."
SO- Blood 99, no. 8 (2002): 3014-3018.
UM- ped-Pegelow, Charles H. / AU- Perkins, C., and C.N. Kim and G.F. Fang and K.N. Bhalla
TI- "Arsenic induces apoptosis of multidrug-resistant human myeloid leukemia cells that express Bcr-Abl or overexpress MDR, MRP, Bcl-2, or Bcl-x(L)."
SO- Blood 95, no. 3 (2000): 1014-1022.
UM- mdd-Bhalla, Kapil N. / AU- Rukavina, D., and G. Laskarin and G. Rubesa and N. Strbo and I. Bedenicki and D. Manestar and M. Glavas and S.E. Christmas and E.R. Podack
TI- "Age-related decline of perforin expression in human cytotoxic T lymphocytes and natural killer cells."
SO- Blood 92, no. 7 (1998): 2410-2420.
UM- mic-Podack, Eckhard R. / AU- Sparano, J.A., and E. Weller and T. Nazeer and T. Habermann and A.E. Traynor and J. Manalo and P.A. Cassileth
TI- "Phase 2 trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with poor-prognosis, intermediate-grade non-Hodgkin lymphoma: an Eastern Cooperative Oncology Group trial (E3493)."
SO- Blood 100, no. 5 (2002): 1634-1640.
UM- mdd-Cassileth, Peter A. / AU- Tallman, M.S., and D. Neuberg and J.M. Bennett and C.J. Francois and E. Paletta and P.H. Wiernik and G. Dewald and P.A. Cassileth and M.M. Oken and J.M. Rowe
TI- "Acute megakaryocytic leukemia: the Eastern Cooperative Oncology Group experience."
SO- Blood 96, no. 7 (2000): 2405-2411.
UM- mdd-Cassileth, Peter A. / AU- Walters, M.C., and R. Storb and M. Patience and W. Leisenring and T. Taylor and J.E. Sanders and G.E. Buchanan and Z.R. Rogers and P. Dinndorf and S.C. Davies and I.A.G. Roberts and R. Dickerhoff and A.M. Yeager and L. Hsu and J. Kurtzberg and K. Ohene-Frempong and N. Bunin and F. Bernaudin and W.Y. Wong and J.P. Scott and D. Margolis and E. Vichinsky and D.A. Wall and A.S. Wayne and C. Pegelow and R. Redding-Lallinger and J. Wiley and M. Klemperer and W.C. Mentzer and F.O. Smith and K.M. Sullivan
TI- "Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report."
SO- Blood 95, no. 6 (2000): 1918-1924.
UM- ped-Pegelow, Charles H. / AU- Wayne, A.S., and S.E. Schoenike and C.H. Pegelow
TI- "Financial analysis of chronic transfusion for stroke prevention in sickle cell disease."
SO- Blood 96, no. 7 (2000): 2369-2372.
UM- ped-Pegelow, Charles H. / AU- Wen, J.H., and N. Ramadevi and D. Nguyen and C. Perkins and E. Worthington and K. Bhalla
TI- "Antileukemic drugs increase death receptor 5 levels and enhance Apo-2L-induced apoptosis of human acute leukemia cells."
SO- Blood 96, no. 12 (2000): 3900-3906.
UM- mdd-Bhalla, Kapil N. /
|
 |
|
|
